RONALD ASBURY ANDREWS
CIK 1299153 · Former CEO · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$349.1K
Companies
7
Total Filings
60
Lifetime Open-Market Net
$43.28M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PSTV | Director | — | $5.01 | — | $0 | 1 | 2026-05-18 |
| PRPO | Director | 15,796 | $22.10 | $349.1K | $0 | 18 | 2026-01-20 |
| Insight Molecular Diagnostics Inc. (OCX) Delisted | Former CEO | 583,212 | $3.20 | $1.87M | $43.07M | 15 | 2022-12-09 |
| Oxford Immunotec Global PLC (OXFD) Delisted | Director | 4,081 | — | — | $0 | 6 | 2020-06-26 |
| LIFE | President, Medical Sciences | 0 | $15.61 | $0 | $154.8K | 7 | 2014-02-04 |
| CLARIENT, INC (CLRT) Delisted | Vice-Chairman and CEO | 0 | — | — | $53.0K | 7 | 2010-12-23 |
| Cardiac Science CORP (CSCX) Delisted | Director | 0 | — | — | $0 | 5 | 2010-12-06 |
Recent Filings · Page 2 of 6
60 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-07-16 | PRPO | Grant (A) | +2,157 | $10.0K | EDGAR |
| 2024-06-25 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2024-04-17 | PRPO | Grant (A) | +3,153 | $21.0K | EDGAR |
| 2023-10-26 | PRPO | Grant (A) | +4,005 | $0 | EDGAR |
| 2023-09-14 | PRPO | Grant (A) | +6,060 | $0 | EDGAR |
| 2023-01-10 | PRPO | Grant (A) | — | $0 | EDGAR |
| 2022-12-09 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Mixed | +250,000 | $0 | EDGAR |
| 2022-08-18 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +40,000 | $38.4K | EDGAR |
| 2022-03-17 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-17 | Insight Molecular Diagnostics Inc. (OCX) Delisted | Buy (P) | +50,000 | $64.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.